The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Correlates of Hepatitis C Virus Infections among Injection Drug Users
Abstract
Injection drug users are at high risk for hepatitis C virus (HCV) infection. In Baltimore, Maryland, the prevalence of anti-HCV is greater among injection drug users who are black, human immunodeficiency virus (HIV) infected, have injected longer, have injected more frequently, and have injected cocaine than among other injection drug users. HCV infection occurs quickly after the initiation of injecting illicit drugs, with 78% of study participants anti-HCV positive after 2 years of injecting. The prevalence of anti-HCV among injection drug users does not appear to be related to socioeconomic factors or sexual practices. Some injection drug users remain free of anti-HCV even after years of injecting and serologic evidence of other bloodborne pathogens. Some of these injection drug users have HCV infection, demonstrated by HCV RNA in their sera. However, the basis for viral persistence in the absence of anti-HCV and for the absence of HCV infection in long-term drug users is not known. Further studies are indicated to determine the mechanism or mechanisms for the absence of anti-HCV in persons exposed to the virus, because the biologic basis for this condition may elucidate the elements missing in the immune response of the majority of HCV-exposed persons who acquire persistent infection. In addition, interventions to prevent HCV infections should be applied in populations at risk for injection drug use early or before drug use begins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alter, H. J., Purcell, R. H., Shih, J. W., Melpolder, J. C., Houghton, M., Choo, Q.-L., & Kuo, G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212202 · Cited by 1,658
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R. H., et al. (1990) · Hepatology · doi:10.1002/hep.1840120409 · Cited by 1,217
Alter, M. J. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450170079026 · Cited by 615
Risk Factors for Human Immunodeficiency Virus Infection in Intravenous Drug Users
Schoenbaum, E. E., Hartel, D., Selwyn, P. A., Klein, R. S., Davenny, K., Rogers, M., Feiner, C., & Friedland, G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909283211306 · Cited by 494
Evaluation of Antibodies to Hepatitis C Virus in a Study of Transfusion-Associated Hepatitis
Esteban, J. I., González, A., Hernández, J. M., Viladomiu, L., Sánchez, C., López-Talavera, J. C., Lucea, D., Martin-Vega, C., Vidal, X., Esteban, R., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010183231605 · Cited by 383
Hepatitis C in Hospital Employees with Needlestick Injuries
Kiyosawa, K., Sodeyama, T., Tanaka, E., Nakano, Y., Furuta, S., Nishioka, K., Purcell, R. H., & Alter, H. J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-367 · Cited by 330
Heterosexual Co-transmission of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)
Eyster, M. E., Alter, H. J., Aledort, L. M., Quan, S., Hatzakis, A., & Goedert, J. J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-10-764 · Cited by 301
High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus
Esteban, R., López-Talavera, J. C., Genescà, J., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-443 · Cited by 279
Hepatitis B and Hepatitis C in Emergency Department Patients
Kelen, G. D., Green, G. B., Purcell, R. H., Chan, D. W., Qaqish, B. F., Sivertson, K. T., & Quinn, T. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205213262105 · Cited by 267
Cited by
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Dube, S. R., Felitti, V. J., Dong, M., Chapman, D. P., Giles, W. H., & Anda, R. F. (2003) · Pediatrics · doi:10.1542/peds.111.3.564 · Cited by 2,333
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Self-citationBica, I., McGovern, B., Dhar, R., Stone, D., McGowan, K., Scheib, R., & Snydman, D. R. (2001) · Clinical Infectious Diseases · doi:10.1086/318501 · Cited by 974
Hepatitis C virus infection in USA: an estimate of true prevalence
Chak, E., Talal, A. H., Sherman, K. E., Schiff, E. R., & Saab, S. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02494.x · Cited by 396
Metadata
- Authors
- Thomas, D. L., Vlahov, D., Solomon, L., Cohn, S., Taylor, E., Garfein, R., & Nelson, K. E.
- Venue
- Medicine
- Published
- 1995-07
- Volume
- 74
- Issue
- 4
- Pages
- 212-220
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2050619287
- Cited by
- 362
- References
- 18
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Correlates of Hepatitis C Virus Infections among Injection Drug Users. https://app.cochat.ai/papers/10.1097/00005792-199507000-00005
- The paper
- Thomas, D. L., Vlahov, D., Solomon, L., Cohn, S., Taylor, E., Garfein, R., & Nelson, K. E. (1995). Correlates of Hepatitis C Virus Infections among Injection Drug Users. Medicine. https://doi.org/10.1097/00005792-199507000-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.